Table 1 Clinical characteristic of a study group
From: Developing a novel positronium biomarker for cardiac myxoma imaging
Patient ID | Sex | Age | Tumor localization | Tumor type | Tumor size (cm) | Metabolic disease | Cardiovascular disease | Diabetes |
|---|---|---|---|---|---|---|---|---|
1 | F | 78 | Left atrium | Solid | 3 × 3 | Hyperlipidemia | Hypertension, Ischemic heart disease, patent foramen ovale | – |
2 | M | 57 | Left atrium | Papillary | 8 × 3 | Extreme obesity | Paroxysmal atrial fibrillation, hypertension | – |
3 | F | 59 | Left atrium | Papillary | 6 × 5 | – | Hypertension, ischemic heart disease | Type II |
4 | F | 84 | Left atrium | Solid | 3.5 × 2.5 | Gout, hypercholesterolemia | Hypertension, paroxysmal atrial fibrillation, varicose veins, ischemic heart disease | - |
5 | F | 52 | Left atrium | Solid | 3 × 2 | – | – | – |
6 | M | 64 | Left atrium | Solid | 2 × 2 | Hypercholesterolemia chronic renal failure | Fixed atrial fibrillation, peripheral atherosclerosis, congestive heart failure | – |